Day Lucy

CIK 00019145101 companyMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001914510

Recent Transactions

18 trades

Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-03-19+73,665→ 73,665 total
Disposition to Issuer
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-03-19−82,300→ 0 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-03-19+82,300→ 82,300 total
Disposition to Issuer
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-03-19−66,000→ 0 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-03-19+66,000→ 66,000 total
Disposition to Issuer
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-03-19−73,665→ 0 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-02-20−77,000→ 77,000 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2026-02-20+38,000→ 118,363 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2026-01-06$1.01/sh−5,512→ 75,363 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2026-01-05$1.00/sh−3,295→ 80,875 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-02-26+46,500→ 79,170 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2025-02-26−93,000→ 93,000 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-01-03$1.34/sh−2,957→ 32,670 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2024-03-15+55,000→ 55,000 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-03-15+27,500→ 30,627 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-03-15+27,500→ 30,627 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2023-02-15+82,300→ 82,300 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2022-05-12+66,000→ 66,000 total

Companies

AN2 Therapeutics, Inc.
Chief Financial Officer
$ANTX

Recent Filings

Address

C/O AN2 THERAPEUTICS, INC. 1300 EL CAMINO REAL, SUITE 100

MENLO PARK, CA, 94025

View on SEC.gov